The Development of an Athletic Performance Predictive Genetic Test

2011 ◽  
pp. BMO5
Author(s):  
Vasiliki Chini
Keyword(s):  
Athletic Performance ◽  
Genetic Test ◽  
Predictive Genetic Test

Industry Watch

2003 ◽  
Vol 07 (23) ◽  
pp. 1475-1490
Keyword(s):  
Cancer Treatment ◽  
Athletic Performance ◽  
Cancer Care ◽  
Genetic Test

AustCancer Completes US Cancer Care Acquisition. Biota-Sankyo in Influenza Drug Partnership. Eastland Files Patent for Rota-Vax. GTG Commercializes Genetic Test for Athletic Performance. Meridica Licenses Xcelovair™ to Pfizer. Avesthagen Sets Up US Subsidiaries. Nicholas Piramal Hunting for Global Partners and Researchers in Therapeutic R&D. Cipla Exerts Its Presence in US Market. Unichem's Expansion Plans. Takeda Sues Mylan, Watson and Ranbaxy over Patent Infringements. Yamanouchi's Vesicare Receives USFDA Approval for Launch. TaiGen and TTY Biopharm Co-develop Cancer Treatment Drug.

Olympic Genes on the Podium?

2016 ◽  
Vol 11 (7) ◽  
pp. 973-974
Author(s):  
Fabian Sanchis-Gomar ◽  
Helios Pareja-Galeano ◽  
Jose A. Rodriguez-Marroyo ◽  
Jos J. de Koning ◽  
Alejandro Lucia ◽  
...  
Keyword(s):  
Experimental Evidence ◽  
Human Genome ◽  
Athletic Performance ◽  
Genetic Test ◽  
Complex Trait ◽  
Animal Research ◽  
Rapid Changes ◽  
Physical Abilities ◽  
Simple Characteristic ◽  
Selection For

Despite some advances, it remains largely unknown how the millions of variations in the human genome influence athletic performance (especially in endurance events), and no single genetic test can really predict sports talent. However, there is experimental evidence from animal research that selecting for even a simple characteristic such as running ability can produce comparatively large and rapid changes in performance. That such selection has not been specifically documented in humans is more evidence of the limits of physiology-archeology than of the unlikelihood of selection for physical abilities. Here, the authors argue that top Olympians are likely genetically gifted individuals who in addition have numerous contributors to the “complex trait” of being an athletic champion that may not necessarily depend on defined genetic variations.

Familial carotid body tumours: is there a role for genetic screening?

2007 ◽  
Vol 122 (9) ◽  
pp. 978-982 ◽  
Author(s):  
P Jani ◽  
A A Qureshi ◽  
S Verma ◽  
L Walker
Keyword(s):  
Early Intervention ◽  
Genetic Testing ◽  
Early Diagnosis ◽  
Carotid Body ◽  
Genetic Screening ◽  
Genetic Test ◽  
Surgical Morbidity ◽  
Clinical Applicability ◽  
Patient Morbidity ◽  
Predictive Genetic Test

AbstractObjective:Carotid body tumours are rare lesions which are familial in 10 per cent of cases. In this paper, we demonstrate the clinical applicability of predictive genetic testing for familial carotid body tumours.Methods:We report a case manifesting with multiple carotid body tumours, in which subsequent genetic testing demonstrated a germline mutation which could be traced across generations. We review the diagnosis and management of carotid body tumours in the familial setting, together with the strategies presently available to screen individuals from susceptible families.Conclusions:The recent advent of a predictive genetic test for familial carotid body tumours offers a novel means of pre-selecting those at risk, so as to minimise screening costs and patient morbidity. Early diagnosis of lesions is essential to allow early intervention, reducing surgical morbidity and progression to malignancy.

Sign in / Sign up

Export Citation Format

Share Document